Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children

Lancet

Volumn 351, Issue 9100, 1998, Pages 404-408

  Örtqvist, Åke ^a   Hedlund, Jonas ^a   Burman, Lars Åke ^c   Elbel, Elisabet ^d   Höfer, Margaret A ^h   Leinonen, Maija ^g   Lindblad, Ingrid ^e   Sundelöf, Bo ^f   Kalin, Mats ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Hospitals of Västerås   (Sweden)

^d Hospitals of Västerås   (Sweden)

^e Hospitals of Västerås   (Sweden)

^f Hospitals of Västerås   (Sweden)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BRONCHIOLITIS; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH CARE UTILIZATION; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; UPPER RESPIRATORY TRACT INFECTION;

EID: 0344541096     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07013-X     Document Type: Article

References (30)

1. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108: 653-57.
2. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-60.
3. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. JAMA 1993; 270: 1826-31.
4. Farr BM, Johnston BL, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk. Arch Intern Med 1995; 155: 2336-40.
5. Austrian R, Douglas RM, Schiffman G, et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976; 89: 184-94.
6. Smit P, Oberholzer D, Hayden-Smith S, Koornhof HJ, Hilleman MR. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977; 238: 2613-16.
7. Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients. N Engl J Med 1986; 315: 1318-27.
8. Davis AL, Aranda CP, Schiffman G, Christianson LC. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease: a pilot study. Chest 1987; 92: 204-12.
9. Leech JA, Gervais A, Ruben FL. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. Can Med Assoc J 1987; 136: 361-65.
10. Fedson DS, Shapiro ED, LaForce FM, et al. Pneumococcal vaccine after 15 years of use. Arch Intern Med 1994; 154: 2531-35.
11. Clemens JD, Shapiro ED. Resolving the pneumococcal vaccine controversy: are there alternatives to randomised clinical trials? Rev Infect Dis 1984; 6: 589-600.
12. Fedson DS, Harward MP, Reid RA, Kaiser DL. Hospital-based pneumococcal immunization. JAMA 1990; 264: 1117-22.
13. Hedlund JU, Örtqvist BÅ, Kalin ME, Scalia-Tomba G, Giesecke J. Risk of pneumonia in patients previously treated in hospital for pneumonia. Lancet 1992; 340: 396-97.
14. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826-31.
15. Örtqvist Å, Hedlund J, Grillner L, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalisation. Eur Respir J 1990; 3: 1105-13.
16. Hedlund JU, Kalin ME, Örtqvist BÅ, Henrichsen J. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Arch Intern Med 1994; 154: 1961-65.
17. Kalin M, Lindberg AA, Tunevall G. Etiological diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates. Scand J Infect Dis 1983; 15: 153-60.
18. Jalonen E, Paton JC, Koskela M, Kerttula Y, Leinonen M. Measurement of antibody responses to Pneumolysin: a promising method for the presumptive etiological diagnosis of pneumococcal pneumonia. J Infect 1989; 19: 127-34.
19. Leinonen M, Syrjälä H, Jalonen E, Kujala P, Herva F. Demonstration of pneumolysin antibodies in circulating immune complexes: a new diagnostic method for pneumococcal pneumonia. Serodiagn Immunother Infect Dis 1990; 4: 451-58.
20. Kauppinen MT, Herva E, Kujala P, Leinonen M, Syrjälä H. The etiology of community-acquired pneumonia among hospitalised patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995; 172: 1330-35.
21. Cox DR, Oaks D. Analysis of survival data. London: Chapman and Hall, 1984.
22. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomised controlled trials. Arch Intern Med 1994; 154: 2666-77.
23. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-88.
24. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae, JAMA 1996; 275: 194-98.
25. Hedlund J, Svenson SB, Kalin M, et al. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis 1995; 21: 948-53.
26. Magnus T, Andersen BM. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in Northern Norway. Eur J Clin Microbiol Infect Dis 1995; 14: 229-34.
27. Gaillat J, Zmirou D, Mallaret MR, et al. Essai clinique du vaccin antipneumococcique chez personnes agées vivant en institution. Rev Epidemiol Santé Publique 1985; 33: 437-44.
28. Macfarlane JT, Ward MJ, Finch RG, Macrae D. Hospital-study of adult community-acquired pneumonia. Lancet 1982; ii: 255-58.
29. British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982-83: a survey of aetiology, mortality, prognostic factors and outcome. QJM 1987; 62 (new series): 195-220.
30. Forrester HC, Jahnigen DW, LaForce FM. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med 1987; 83: 425-30.